Alcentra Capital Corp (ABDC) Expected to Announce Quarterly Sales of $6.35 Million

Wall Street brokerages expect Alcentra Capital Corp (NASDAQ:ABDC) to post sales of $6.35 million for the current quarter, Zacks Investment Research reports. Three analysts have issued estimates for Alcentra Capital’s earnings, with the highest sales estimate coming in at $6.71 million and the lowest estimate coming in at $5.84 million. Alcentra Capital reported sales of $8.18 million during the same quarter last year, which indicates a negative year-over-year growth rate of 22.4%. The business is scheduled to issue its next quarterly earnings report on Monday, May 6th.

According to Zacks, analysts expect that Alcentra Capital will report full-year sales of $25.20 million for the current year, with estimates ranging from $22.93 million to $27.28 million. For the next year, analysts anticipate that the firm will post sales of $27.06 million, with estimates ranging from $22.74 million to $30.00 million. Zacks Investment Research’s sales averages are an average based on a survey of sell-side research firms that follow Alcentra Capital.

Alcentra Capital (NASDAQ:ABDC) last announced its quarterly earnings results on Monday, March 11th. The asset manager reported $0.27 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.22 by $0.05. Alcentra Capital had a return on equity of 9.24% and a net margin of 19.06%. The firm had revenue of $6.98 million during the quarter, compared to analyst estimates of $6.62 million.

Several institutional investors have recently made changes to their positions in ABDC. Virtu Financial LLC purchased a new position in shares of Alcentra Capital in the 4th quarter valued at about $90,000. Millennium Management LLC purchased a new stake in Alcentra Capital during the 4th quarter worth approximately $107,000. Squarepoint Ops LLC purchased a new stake in Alcentra Capital during the 4th quarter worth approximately $165,000. Two Sigma Investments LP purchased a new stake in Alcentra Capital during the 4th quarter worth approximately $265,000. Finally, Mackenzie Financial Corp increased its stake in Alcentra Capital by 73.1% during the 3rd quarter. Mackenzie Financial Corp now owns 69,744 shares of the asset manager’s stock worth $417,000 after buying an additional 29,458 shares in the last quarter. Hedge funds and other institutional investors own 29.83% of the company’s stock.

Shares of Alcentra Capital stock traded up $0.06 on Friday, hitting $7.92. The company’s stock had a trading volume of 60,840 shares, compared to its average volume of 39,855. Alcentra Capital has a 1 year low of $5.58 and a 1 year high of $8.16. The firm has a market cap of $101.98 million, a PE ratio of 7.84 and a beta of 0.58.

The firm also recently declared a quarterly dividend, which was paid on Thursday, April 4th. Investors of record on Friday, March 29th were paid a $0.18 dividend. The ex-dividend date was Thursday, March 28th. This represents a $0.72 annualized dividend and a dividend yield of 9.09%. Alcentra Capital’s dividend payout ratio is presently 71.29%.

Alcentra Capital Company Profile

Alcentra Capital Corporation is a business development company specializing in investments in lower middle-market companies. The fund seeks to invest in healthcare, business services, defense, government services, telecom and technology, media, infrastructure maintenance and logistics, and oil and gas services sector.

See Also: The risks of owning bonds

Get a free copy of the Zacks research report on Alcentra Capital (ABDC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Alcentra Capital (NASDAQ:ABDC)

Receive News & Ratings for Alcentra Capital Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alcentra Capital and related companies with MarketBeat.com's FREE daily email newsletter.